Publications by authors named "Marco Cefali"

Claim this Profile
T
The active involvement of patients in oncology research.
Ursula Ganz-Blaettler, Sarah Jayne Liptrott, Angela Tolotti, Marco Cefalì, Christine Aeschlimann

Cancer Treat Rev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neo-RAS Wild Type or RAS Conversion in Metastatic Colorectal Cancer: A Comprehensive Narrative Review.
Guido Pesola, Samantha Epistolio, Marco Cefalì, Elena Trevisi, Sara De Dosso

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis.
Caroline-Claudia Erhart, Marco Cefalì, Dylan Mangan, Benjamin Kasenda, Luciano Wannesson

Swiss Med Wkly· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?
Marco Cefalì, Isabel Scala, Giuliana Pavone, Daniel Helbling, Saskia Hussung

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes.
Raffaello Roesel, Letizia Deantonio, Lorenzo Bernardi, Maria Luisa Garo, Pietro Majno-Hurst

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review.
Stefania Rizzo, Isabel Scala, Angela Rodriguez Robayo, Marco Cefalì, Sara De Dosso

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers.
Elona Cekani, Samantha Epistolio, Giulia Dazio, Marco Cefalì, Luciano Wannesson

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy.
Marco Cefalì, Samantha Epistolio, Giulia Ramelli, Dylan Mangan, Francesca Molinari

J Clin Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDG PET Radiomics as Predictor of Treatment Response in Oesophageal Cancer: A Systematic Review and Meta-Analysis.
Letizia Deantonio, Maria Luisa Garo, Gaetano Paone, Maria Carla Valli, Stefano Cappio, Marco Cefali

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab.
Samantha Epistolio, Marco Cefalì, Paolo Spina, Francesca Molinari, Alessandra Movilia

Oncotarget· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis